|
(MoneyNewsWire.Net, April 30, 2016 )
OVERVIEW OF THE PHARMACEUTICAL MARKET IN MYANMAR
Despite its small size, Myanmar's pharmaceutical market offers drugmakers strong revenue-earning opportunities. Generic and over-the-counter drug companies in particular stand to benefit, as the population's per capita expenditure on pharmaceuticals and healthcare remains low but set to rise. However we believe that the country remains a high-risk market as a result of political risks arising from ethnic tensions, in addition to the challenging economic framework - the result of corruption and unclear regulations.
Headline Expenditure Projections
Pharmaceuticals: MMK241.2bn (US$280mn) in 2012 to MMK279.5bn (US$320mn) in 2013; +15.9% in local currency terms and 14.1% in US dollar terms.
Healthcare: MMK992.5bn (US$1.1bn) in 2012 to MMK1,098.4bn (US$1.3bn) in 2013; +10.7% in local currency terms and +9.0% in US dollar terms.
To Browse a Complete Report with TOC Visit @ http://www.researchmoz.us/the-pharmaceutical-market-myanmar-report.html
Risk/Reward Rating
Myanmar does not feature in our latest Q313 Asia Pacific Pharmaceutical Risk/Reward Ratings (RRR). However, using the tool, BMI notes that the country scores 29.6 out of the maximum 100 under our newly improved RRR system. With the low score, Myanmar is ranked last out of the 18 key markets featured in the region.
Key Trends And Developments
In June 2013, Jang Kyung Won, director general of South Korea's Ministry of Health and Welfare stated that the country is seeking medical collaboration with Myanmar in a long-term medical support and technical exchange. Jang stated that the country will start by providing free operations in South Korea to Myanmar patients who require surgeries that are unavailable in Myanmar.
In the same month, the Irrawaddy reported that the country's public hospitals are offering free medicines to poor patients for the first time.
In April 2013, Harijit Gill, chief executive for the ASEAN and Asia Pacific of Philips Electronics stated that the company is planning to expand its consumer electronics and healthcare business in Myanmar.
BMI Industry View7
SWOT9
Industry Forecast10
Pharmaceutical Market Forecast10
To Download Sample Report With TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=240625
Table: Pharmaceutical Sales, Historical Data And Forecasts (Myanmar 2010-2018)11
Healthcare Market Forecast13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2010-2018)15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2010-2018)16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2010-2018)16
Pharmaceutical Trade Forecast17
Table: Pharmaceutical Trade Data And Forecasts (Myanmar 2012-2018)18
Table: Pharmaceutical Trade Data And Forecasts local currency (Myanmar 2012-2018)18
To Browse a Complete Report with TOC Visit @ http://www.researchmoz.us/the-pharmaceutical-market-myanmar-report.html
Industry Risk Reward Ratings19
Asia Risk/Reward Ratings19
Myanmar Risk/Reward Ratings25
Rewards25
Risks25
Market Overview27
Industry Trends And Developments28
Epidemiology28
Communicable Diseases And Other Injuries28
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Email: sales@researchmoz.us
WebSite:http://www.researchmoz.us/
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
|
